MEDICINES DISCOVERY CATAPULT SERVICES LIMITED

Company number 10305216 · Monitor this company

Dissolved

Shareholders' funds

£1

Balance sheet as at 2017-03-31

View full accounts →

Overview

Company type: Private Limited Company
Incorporated: 2016-08-01
Dissolved: 2024-05-24
Registered office: C/O Mazars Llp, 1st Floor, Two Chamberlain Square, Birmingham, B3 3AX
Postcode: B3 3AX
Capital: 1 GBP
Accounts category: Full

Accounts

Last made up to: 2022-03-31
Financial year end: 31 March

Confirmation statement

View filing history →

Nature of business (SIC)

72190 Other research and experimental development on natural sciences and engineering

Officers 3 current · 3 resigned

Graham John CLARKE Director

Director Appointed 2021-08-04

Lynne ROBB Director

Director Appointed 2021-06-17

DR Robin John, Dr BROWN Director

Director Appointed 2018-07-27

View all officers and resignations →

Group structure

Controlled by MEDICINES DISCOVERY CATAPULT LIMITED — since 2016-08-01

From persons-with-significant-control filings on the public register.

Public contracts won 2

£15,000,076,536 total awarded value where published.

Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study.

UNIVERSITY OF NOTTINGHAM (THE) 2022-05-05 £76,536
National Microbiology Framework - Lot 4 Clinical Laboratory Diagnostic Testing Services

Public Health England 2021-02-23 £15,000,000,000

Contains public sector information licensed under the Open Government Licence v3.0 (Contracts Finder).

Previous registered addresses 1

Address	Changed on
C/O BPE SOLICITORS LLP, FIRST FLOOR, ST JAMES' HOUSE ST. JAMES' SQUARE, CHELTENHAM, GLOUCESTERSHIRE, GL50 3PR, ENGLAND	2016-11-17

The class of 2016

28%

of the 563 companies in this sector incorporated in 2016 are still active today; 67% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →